US FDA

FDA Releases New Augmented Reality and Virtual Reality Resources

US FDA sent this email to their subscribers on September 2, 2023.

FDA released 2 new infographics to help patients and providers weigh risks and benefits of medical XR technology and make informed decisions

This email was sent to [email protected] using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo gOVDELlVERY

Text-only version of this email

FDA released 2 new infographics to help patients and providers weigh risks and benefits of medical XR technology and make informed decisions If your email program has trouble displaying this email, view as a webpage. P Center for Devices N Radiological Health : M !I Bookmark and Share FDA RELEASES NEW AUGMENTED REALITY AND VIRTUAL REALITY RESOURCES FOR PATIENTS, CAREGIVERS, AND HEALTH CARE PROFESSIONALS AR-VR Provider Poster Thumbnail graphic Augmented reality (AR) and virtual reality (VR) headsets may be useful for more than just gaming. Increasingly, they are being used in health care settings as part of medical devices to treat patients with what it is called medical extended reality (XR). Whether health care providers are using these XR devices to assist in surgery or in the treatment of lazy eye in children, for example, the increased use of these devices may leave you with plenty of questions. Don’t worry, we are here to help you figure out what questions to consider asking. AR VR Patient Poster Thumbnail Today, the U.S. Food and Drug Administration (FDA) released two new infographics –  to support patients and caregivers discussing the use of medical XR technology with their health care professionals, and to assist health care professionals deciding whether to use medical XR in their practice. Medical XR may help advance health equity by providing care outside of traditional health care settings such as at home or other non-clinical setting, or when a specialist is not locally available. These resources are based on recommendations from our Patient Engagement Advisory Committee Meeting on AR/VR in 2022, where patients and health care professionals shared with the FDA what information they would want to know before using medical XR technology in their health care or practice. QUESTIONS? If you have questions about the AR/VR infographics, please contact the Digital Health Center of Excellence, email [email protected]. Follow us on Twitter at @FDADeviceInfo twitterfacebookyoutubeLinkedIn Manage Subscriptions  |   |  Help - This email was sent to [email protected] using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA GovDelivery logo gOVDELlVERY
Show all

The Latest Emails Sent By US FDA

More Emails, Deals & Coupons From US FDA

Email Offers, Discounts & Promos From Our Top Stores